Summary: The Centers for Medicare & Medicaid Services modified its intravenous iron therapy coverage policy, effective May 15, 2026. Here's what billing teams need to do.
CMS intravenous iron therapy coverage policy changes affect nephrology, oncology, and infusion billing teams most directly. The policy document does not list specific CPT or HCPCS codes — more on that below. If your practice bills for IV iron infusions under Medicare, review your charge capture and documentation protocols before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Intravenous Iron Therapy |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | High |
| Specialties Affected | Nephrology, Oncology, Hematology, Infusion Therapy, Internal Medicine |
| Key Action | Audit medical necessity documentation and confirm prior authorization requirements with your MAC before May 15, 2026 |
CMS Intravenous Iron Therapy Coverage Criteria and Medical Necessity Requirements 2026
Here's the honest situation: the policy document referenced in this update does not include the full text of the revised coverage criteria. The source link points to a modified policy, but the detailed clinical criteria were not available in the underlying policy data at the time of publication.
That matters because IV iron therapy billing is already a high-denial area. CMS has historically required clear medical necessity documentation before reimbursement for intravenous iron. This modification may tighten, clarify, or expand those requirements — and until the full policy text is published, you're working with incomplete information.
What we know from CMS's historical position on IV iron therapy: coverage applies when oral iron is contraindicated, ineffective, or not tolerated. The most common covered indications include iron deficiency anemia in patients with chronic kidney disease (CKD) on dialysis, and anemia related to cancer treatment. Coverage outside those populations is where denials cluster.
Medical necessity documentation for IV iron under Medicare has always required more than a lab value. You need a documented clinical rationale — why oral iron won't work for this specific patient, not just a low ferritin. A claim denial in this space often traces back to a physician note that references the lab result but skips the clinical reasoning.
If your practice operates under a Medicare Administrative Contractor with a local coverage determination (LCD) for iron infusions, check whether your MAC has issued a parallel update. CMS national coverage changes do not always supersede MAC-level LCDs, and the two can conflict in ways that create billing guidelines confusion.
Talk to your compliance officer before May 15, 2026 if you're unsure how this modification interacts with your MAC's existing LCD. The gap between what CMS says nationally and what your MAC allows locally is where the real exposure sits.
CMS Intravenous Iron Therapy Exclusions and Non-Covered Indications
Because the full policy text is not available, this section reflects CMS's established non-coverage positions for IV iron therapy — not newly stated exclusions from this modification.
CMS does not cover IV iron as a first-line treatment when oral iron is a viable option. If the medical record doesn't document a trial of oral iron, a documented intolerance, or a clinical reason why oral therapy is contraindicated, expect a denial.
IV iron for iron deficiency without anemia is typically not covered. The distinction between iron deficiency (low ferritin, normal hemoglobin) and iron deficiency anemia (low ferritin, low hemoglobin) is one CMS takes seriously. Your documentation needs to show anemia, not just depletion.
Infusions administered in settings that don't match the billed place of service are another common denial trigger. If you're billing for an outpatient hospital infusion and the patient received treatment in a physician office, that mismatch will surface in a post-payment audit.
Coverage Indications at a Glance
The policy document does not include a specific indication-by-indication breakdown. The table below reflects CMS's known coverage positions based on established Medicare policy for IV iron therapy. Verify these against the full updated policy text once CMS publishes it.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Iron deficiency anemia in CKD patients on dialysis | Covered | Confirm with MAC | Medical necessity documentation required; oral iron contraindication must be documented |
| Iron deficiency anemia in cancer patients receiving chemotherapy | Covered | Confirm with MAC | Anemia must be treatment-related; document clinical rationale |
| Iron deficiency without anemia | Not Covered | N/A | Hemoglobin must be below threshold; lab values alone are insufficient |
| IV iron as first-line when oral iron not tried | Not Covered | N/A | Must document oral iron trial, intolerance, or contraindication |
| Maintenance IV iron in non-dialysis CKD | Coverage Varies by MAC | Confirm with MAC | Check your MAC's LCD — national policy and local coverage determinations may differ |
CMS Intravenous Iron Therapy Billing Guidelines and Action Items 2026
| # | Action Item |
|---|---|
| 1 | Pull the full policy text from your MAC before May 15, 2026. The policy change is confirmed. The full criteria are not yet available through the source document. Go directly to your MAC's website or call your MAC provider relations line and ask specifically about any LCD updates tied to this CMS modification. |
| 2 | Audit your medical necessity templates now. If your physicians use a standard order template or attestation form for IV iron, review it against CMS's historical requirements. The template must capture: the clinical indication, the hemoglobin and ferritin values, the reason oral iron is not appropriate, and the planned treatment schedule. A template that captures lab values but skips the clinical rationale will generate denials. |
| 3 | Check your prior authorization workflow. Whether IV iron requires prior authorization under Medicare depends on your MAC and the clinical setting. Some MACs require prior auth for outpatient infusions; others do not. Confirm your MAC's current prior authorization requirements before the effective date of May 15, 2026. |
| 4 | Confirm your HCPCS codes are current. The policy document does not list specific codes — see the section below for detail. This is unusual. It may mean the modification is criteria-based rather than code-based, or the codes were omitted from the published summary. Either way, verify with your MAC that the HCPCS codes your team currently bills for IV iron infusions are still active and correctly mapped to the updated coverage criteria. |
| 5 | Review place-of-service accuracy. IV iron billing spans multiple settings — hospital outpatient departments, physician offices, and infusion centers. Each setting carries different reimbursement rates and coverage requirements. A claim billed with the wrong place-of-service modifier will deny. Audit a sample of recent IV iron claims for POS accuracy before the effective date. |
| 6 | Train your infusion nursing staff on documentation triggers. The clinical staff administering the infusion often complete the infusion record that becomes part of the claim documentation. They need to know what CMS looks for: documented patient tolerance, infusion duration, and any adverse reactions noted. A bare infusion record with start/stop times and nothing else creates audit risk. |
| 7 | Talk to your compliance officer if you bill across multiple specialties. If IV iron therapy crosses nephrology, oncology, and hematology in your system, the medical necessity criteria differ by indication. A single documentation template will not cover all three populations. Your compliance officer should review whether specialty-specific templates are warranted. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Intravenous Iron Therapy Under This Policy
The policy document does not list specific CPT, HCPCS, or ICD-10 codes. This is a meaningful gap.
For IV iron therapy billing, the HCPCS codes your team typically uses are tied to the specific iron formulation — different iron products carry different HCPCS codes. CMS coverage and reimbursement rates can vary by formulation. Do not assume that a policy modification covering "intravenous iron therapy" broadly applies identically to every iron product your practice uses.
Contact your MAC directly and ask which HCPCS codes fall under this modified coverage policy. Request written confirmation if you can get it. If your MAC has issued or updated an LCD for IV iron, that document will list the applicable codes explicitly.
Until the full code list is published, do not change your current code assignments based on this alert alone. Audit your existing charge capture against the modified policy once the full text is available.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.